12 Sep, 2019 image
search_img

Global Telehealth is On the Rise

By Nina Deka, Senior Research Analyst, ROBO Global The National Healthcare Security Administration of China issued its anticipated guidelines on pricing and insurance coverage for internet medical services, marking a significant milestone for telemedicine adoption in China. This news is in line with our view that global telehealth adoption is accelerating, and is a positive catalyst for the ROBO Global Healthcare Technology and Innovation Index (HTEC). Ping An Healthcare and Technology Compan...

Learn More
22 Aug, 2019 image
search_img

How Teladoc is Transforming Access to Healthcare

By Nina Deka, Senior Research Analyst, ROBO Global Lack of access to healthcare and rapidly growing healthcare costs are two critical issues impacting the US economy, and they remain consistent topics of debate among policy makers. Telemedicine, a service that connects a patient to a doctor remotely, has seen rapid growth in the last few years because it addresses both of these issues. Teladoc Health, a ROBO Global Healthcare Technology & Innovation Index (HTEC) member, pioneered the tele...

Learn More
8 Aug, 2019 image
search_img

Spotlight on the AI pioneer behind Sophia the Robot: Ben Goertzel

Last week, I was thrilled to have the opportunity to interview one of the brightest minds in robotics and AI today: Ben Goertzel. As the chief scientist at Hanson Robotics, the company that created the AI robot Sophia, Ben is a true innovator and a visionary in the field. He is a founder and the current CEO of SingularityNET, a company that focuses on bringing AI and blockchain together to create a decentralized open market for AI; the chairman of the Artificial General Intelligence Society and ...

Learn More
5 Aug, 2019 image
search_img

Turnkey Tech Investing: July 2019 Market Brief

For the first half of the year, the emphasis for the market overall was on the “climb.” Recently, however, the challenge has been getting the upper hand. For those with a short-term time horizon, it will be challenging to understand central bank policies or the ultimate outcome of the escalating global trade war. While these issues have most certainly presented a challenge, for those with their eyes on the long-term destination, recent investments in the theme point to future growth. In ...

Learn More
2 Aug, 2019 image
search_img

Giving viruses a taste of their own medicine

New technology is exploiting a virus’s capability to enter the human body and deliver therapy, rather than disease.  It’s called a viral vector, and it’s one of the fastest growing themes in precision medicine due to its increasing accuracy in treating rare diseases. Here is a brief look at this innovative technology, and the genomics and precision medicine companies within the ROBO Global Healthcare Technology and Innovation Index (HTEC) that provide investors with exposure to this them...

Learn More
25 Jul, 2019 image
search_img

Qiagen: The most ubiquitous company in molecular diagnostics

With over 500,000 customers, Qiagen’s products are used in almost every molecular biology lab in the world. Qiagen’s “Sample to Insight” mission aims to offer end-to-end solutions to clinical labs and life science companies. The company has the #1 market leadership position in sample technologies that are used in every application in molecular biology (e.g. liquid biopsy, CRISPR, AAV). Qiagen’s strategy is to leverage its large client base to cross-sell its new solutions, including ful...

Learn More
28 Jun, 2019 image
search_img

Tecan: Enabling the disruption of life science and diagnostics

At a recent visit to our New York office, Achim von Leoprechting, the new CEO of Switzerland-based Tecan, shared how the Swiss company’s technology is helping to revolutionize the life sciences industry. Following our conversation, we remain bullish on the long-term growth outlook for this market leader in lab automation for life science and research organizations. What does the company do exactly? Tecan provides the chassis, nuts, and bolts that enable genomic research and drug discovery—tw...

Learn More
28 Jun, 2019 image
search_img

Investing in healthcare technology and innovation

At ROBO Global, we believe robotics, automation, and AI to be the next technological revolution—perhaps the most important in our lifetime. It is a global shift that is comparable to the introduction of electricity in the early 20th century and, more recently, to the adoption of the Internet and mobile technologies over the last two decades. To enable investors to gain exposure to best-in-class companies across these key robotics and AI applications, ROBO Global created the ROBO Global Roboti...

Learn More
24 May, 2019 image
search_img

AI: Shaping the Future of Healthcare

Healthcare stands out as one of the least digitized economic sectors and a bona fide latecomer to the opportunity of automation. While other industries have made great strides leveraging the power of automation everywhere from the factory floor to the living room floor, healthcare had seemed content to remain in a state of complacency, with extremely low productivity gains in the past decade. Even as robot-assisted surgery was making headlines, the rest of the healthcare supply chain seemed stuc...

Learn More
9 May, 2019 image
search_img

Investing in the promise of a longer life

At long last, the healthcare industry is undergoing a massive transformation. It’s a past-due shift in an area that seemed to remain stagnant for decades, even as the world around it evolved at a rapid pace. But new technologies are finally making change possible, moving from a healthcare model focused on caring for the sick to one that is focused on prediction, prevention, and the eradication of disease. The expected result: a longer lifespan—as well as a plethora of new investment opportun...

Learn More
load more
  • 788 Followers
  • Subscribeto RSS Feed

Popular & Recent News

Recent White Papers

Categories

You are now leaving the ROBO Global website

You are now leaving the ROBO Global website. The following landing page may contain information concerning investments, products or other information. Exchange Traded Concepts LLC, the Fund Advisor are not responsible for the accuracy or completeness of information on non-affiliated websites. The material available on non-affiliated websites has been produced by the entities that are not affiliated with Exchange Traded Concepts LLC. Descriptions of, references to, or links to products or publications within any non-affiliated linked website does not imply endorsement of that product or publication by Exchange Traded Concepts LLC. Any opinions or recommendations from non-affiliated websites are solely those of the independent providers and are not the opinions or recommendations of Exchange Traded Concepts LLC, which is not responsible for any inaccuracies or errors.

Proceed

Dismiss

You are now leaving the ROBO Global website

You are now leaving the ROBO Global, LLC website and being directed to ETF Securities (UK) Limited which is authorized and regulated by the United Kingdom Financial Conduct Authority (the “FCA”). By clicking “OK”, you acknowledge that you are someone authorized to undertake investment activities relating to the Exchange Traded Funds (ETFs). IN addition, you understand that ROBO Global, LLC is not making any financial promotion or carrying out any regulated activity of said products. The following landing page may contain information concerning investments, products or other information. ETF Securities (UK) Limited is not responsible for the accuracy or completeness of information on non-affiliated websites. The material available on non-affiliated websites has been produced by entities that are not affiliated with ETF Securities (UK) Limited. Descriptions of references to, or links to products or publications within any non-affiliated linked websites does not imply endorsement of that product or publication by ETF Securities (UK) Limited. Any opinions or recommendations from non-affiliated websites are solely those of the independent providers and are not the opinions or recommendations of ETF Securities (UK) Limited, which is not responsible for any inaccuracies or errors.

Proceed

Dismiss

You are now leaving the ROBO Global website

You are now leaving the ROBO Global, LLC website and being directed to ETFS Management (AUS) Limited which is authorized and regulated by the Australian Securities and Investments Commission (“ASIC“). By clicking “OK”, you acknowledge that you are someone authorized to undertake investment activities relating to the Exchange Traded Funds (ETFs). In addition, you understand that ROBO Global, LLC is not making any financial promotion or carrying out any regulated activity of said products. The following landing page may contain information concerning investments, products or other information. ETFS Management (AUS) Limited is not responsible for the accuracy or completeness of information on non-affiliated websites. The material available on non-affiliated websites has been produced by entities that are not affiliated with ETFS Management (AUS) Limited. Descriptions of references to, or links to products or publications within any non-affiliated linked websites does not imply endorsement of that product or publication by ETFS Management (AUS) Limited. Any opinions or recommendations from non-affiliated websites are solely those of the independent providers and are not the opinions or recommendations of ETFS Management (AUS) Limited, which is not responsible for any inaccuracies or errors.

Proceed

Dismiss